by Artificial Insemination (AI) is a reproductive technique that involves surgically placing sperms into a female’s uterus or cervical canal. It assists in the genetic improvement of cattle by allowing beef and dairy farmers to choose high quality sires and breed cows accordingly. AI makes it possible to use sperm from elite beef and dairy bulls that have proven records for production, health, fertility and conformation. This allows livestock farms to breed cows with bulls known for passing on desirable genetic traits like increased milk production, beef quality or disease resistance. Widespread use of AI techniques means farmers no longer need to keep bulls on their premises, reducing infrastructure and management costs.
The global Artificial Insemination Market is estimated to be valued at US$ 10.6 Mn in 2024 and is expected to exhibit a CAGR of 8.1% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends
Sexed semen is one of the key trends shaping the artificial insemination market. Sexed semen allows farmers to breed only female cattle as dairy females have higher production and longevity compared to males. The sexed semen technology filters X-chromosome and Y-chromosome-bearing sperm, allowing over 90% chance of producing female offspring. The technology increases productivity and reduces rearing costs on farms. It is forecast to witness strong adoption over the forecast period, driving revenue growth of artificial insemination market players.
Porter’s Analysis
Threat of new entrants: Low capital requirements and fewer switching costs allow for the entry of new players in the market. However, established brands dominate the market through extensive R&D and strategic partnerships.
Bargaining power of buyers: Buyers have moderate bargaining power due to the availability of substitutes and options. However, customized solutions and personalized care increase customer retention.
Bargaining power of suppliers: A few large companies control the supply of key components and materials. Stable supply chains help maintain steady pricing and production.
Threat of new substitutes: Alternatives like intrauterine insemination pose competition, but artificial insemination offers higher success rates and customized solutions.
Competitive rivalry: Large players focus on innovations to strengthen their market shares. Strategic collaborations and regional expansion characterize the competitive landscape.
Key Takeaways
The global Artificial Insemination Market Demand is expected to witness high growth. The global Artificial Insemination Market size is estimated to be valued at US$ 10.6 Mn in 2024 and is expected to exhibit a CAGR of 8.1% over the forecast period 2024 to 2031.
North America dominates due to favorable reimbursement policies and increasing infertility rates. Factors like delayed pregnancies, rising obesity, and stress levels contribute to the growth. Europe and Asia Pacific will grow at the fastest pace during the forecast period. The growing affluence, acceptance of advanced treatments, and rising healthcare spends will drive the European market. Fertility tourism and initiatives by the Indian government propel the market in Asia Pacific.
Key players operating in the artificial insemination market are Pride Angel, Irvine Scientific, Hi-Tech Solutions, Rinovum Women’s Health, LLC, TenderNeeds Fertility, Conceivex, Inc., Labotech GmbH, Hamilton Throne Ltd., Biogenics Inc., Nikon Instruments Inc., Zander scientific Inc., and Surelife Pte Ltd. Companies focus on partnerships, clinical trials, and new product launches to expand their service offerings.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
